We’re witnessing greater market volatility amid the latest COVID mutation. As 2022 looms, here are the risks and rewards for investors. Read More

The IPO market can be lucrative if you're able to buy shares at the offering price. You can't, but there's still a way to profit. Read More

Now may be an opportune time to buy a put option on this soaring airline ETF, after drugmakers announced encouraging COVID-19 vaccine results. Read More

Economic prospects are bright for 2021, but in the interim, the journey will be rough. Here are the challenges and opportunities ahead. Read More

Over the past three months, Novavax has lost nearly half its value. That's about to change, and here is how you can profit. Read More

The end of electioneering and the emergence of COVID vaccines are fueling a relief rally in stocks. A bull market probably awaits investors in 2021. Read More

For companies that have seen their share prices soar, soon may be the time to use that stock as currency to buy other businesses. Read More

Wall Street is enthralled by a new coronavirus vaccine rushed forward by Vladimir Putin that hasn’t been properly tested. That’s a recipe for disaster. Read More

Wall Street's delusions are about to collide with reality, especially over false hopes for an imminent coronavirus vaccine. Read More